A restrospective analysis of toxicities encountered with palliative epirubicin, oxaliplatin, and capecitabine (EOX) chemotherapy for advanced esophagogastric cancer.

被引：1

作者：

Khakoo, Shelize Sadrudin ^{[1
]}

Georgiou, Alexandros ^{[1
]}

Waters, Justin S. ^{[1
]}

机构：

[1] Kent Oncol Ctr, Maidstone, Kent, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期

关键词：

D O I：

10.1200/jco.2014.32.3_suppl.162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

162

引用

页数：1

共 50 条

[41] Randomised trial of capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx)in advanced pancreatic cancer.
Heinemann, V
Golf, A
Seipelt, G
Bauer, J
Höhler, T
Clemens, M
Löhr, JM
Stauch, M
Lordick, F
Hinke, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 340S - 340S
[42] Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
Okines, Alicia F. C.
Ashley, Sue E.
Cunningham, David
Oates, Jacqueline
Turner, Andrea
Webb, Janine
Saffery, Claire
Chua, Yu Jo
Chau, Ian
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) : 3945 - 3950
[43] The validity and safety 1st-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer
Yoshiaki, Shindo
[J]. ANNALS OF ONCOLOGY, 2017, 28
[44] A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
Yun, Jina
Lee, Jeeyun
Park, Se Hoon
Park, Joon Oh
Park, Young Suk
Lim, Ho Yeong
Kang, Won Ki
[J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 885 - 891
[45] Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer
Markus Moehler
Rolf Mahlberg
Volker Heinemann
Radka Obermannová
Eugen Kubala
Bohuslav Melichar
Arndt Weinmann
Paul Scigalla
Marietta Tesařová
Petr Janda
Fabienne Hédouin-Biville
Wasat Mansoor
[J]. Gastric Cancer, 2017, 20 : 358 - 367
[46] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
Natoli, C.
Cianchetti, E.
Ficorella, C.
Angelucci, D.
Grossi, S.
Noccioli, P.
Ricevuto, E.
Grassadonia, A.
Zilli, M.
Di Giacobbe, A.
Rispoli, A., I
Tinari, N.
Iacobelli, S.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
[47] A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer
Cho, EK
Lee, WK
Im, SA
Lee, SN
Park, SH
Bang, SM
Park, DK
Park, YH
Shin, DB
Lee, JH
[J]. ONCOLOGY, 2005, 68 (4-6) : 333 - 340
[48] A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer
Villman, Kenneth
Ohd, John F.
Lidbrink, Elisabet
Malmberg, Lena
Lindh, Birgitta
Blomqvist, Carl
Nordgren, Hans
Bergh, Jonas
Bergstrom, Daniel
Ahlgren, Johan
[J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1153 - 1160
[49] Optimizing doses of a first line chemotherapy treatment containing epirubicin, paclitaxel and capecitabine (TEX) in metastatic breast cancer.
Einbeigi, Z
Bergström, D
Hatschek, T
Malmberg, M
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S131 - S131
[50] Preoperative chemoradiotherapy (QT-RT) with capecitabine and oxaliplatin (CAPOX) in patients with locally advanced rectal cancer.
Sancho, Aintzane
Marrodan, Ines
Calvo, Begona
Munoz, Alberto
Manel Mane, Joan
Carrera, Sergio
Fuente, Natalia
Azkona, Eider
Arruti, Mikel
Isabel Gutierrez, Eddy
Ugalde, Irene
Lopez-Vivanco, Guillermo
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

← 1 2 3 4 5 →